“The present situation has exposed some structural weaknesses in the EU’s medicines source chain and a substantial dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She recommended that supply chain challenges be resolved within an EU pharmaceutical system envis… Read More